Country | Author | Incidence rate per 100,00 | Prevalence rate | Source of data |
---|---|---|---|---|
West Africa | ||||
Nigeria | Osegbe, 1998 [32] | 127.0 | - | Hospital-based data; for men 45 years or older |
Nigeria | Ekwere & Egbe, 2002 [37] | 61.3 | - | Hospital-based data; for men 35 years or older |
Nigeria | Eke & Sapira, 2002 [33] | 114.0 | - | Hospital-based data; for men 45 years or older |
Nigeria | Ukoli et al., 2003 [26] | - | 15.7% | Rural Nigerian population-based; PSA = 4 ng/mL for men 50 years & older |
Caribbean | ||||
Jamaica | Glover et al., 1998 [10] | 304.0 | - | Large population-based study; age-adjusted rate |
Jamaica | Hanchard et al., 2001 [19] | 56.4 | - | Cancer registry data; age-adjusted rate |
Tobago | Bunker et al., 2002 [22] | - | 10.0% | Large population-based study; biopsy confirmed for men 40–79 years |
Tobago | Bunker et al., 2004 [21] | - | 10.7% | Large population-based study; biopsy confirmed for men 40–79 years |
Brazil | Barros et al., 2003 [16] | - | 19.7% | Hospital-based data; for men 40–79 years |
Europe | ||||
United Kingdom | Chinegwundoh et al., 2006 [24] | 647.0 | - | Population-based audit for African-Caribbean (all blacks); age-adjusted rate for men 50 years or older over 2 years |
United Kingdom | Ben-Shlomo et al., 2007 [25] | 165.5 | - | Population-based audit for African-Caribbean (all Blacks); age-adjusted rate for men 50 years or older over 5 years |
United Kingdom | Ben-Shlomo et al., 2007 [25] | 173.1 | - | Population-based audit for Black Caribbean; age-adjusted rate for men 40 years or older over 5 years |
United Kingdom | Ben-Shlomo et al., 2007 [25] | 139.3 | - | Population-based audit for Black African (all blacks); age-adjusted rate for men 40 years or older over 5 years |
United States | ||||
US Black Men | ACS, 2008 [1] | 258.30 |  | SEER 2000 – 2003 data |